Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Vanda Pharmaceuticals Inc. | SVP & General Counsel | Common Stock | 197K | $823K | $4.18 | Mar 5, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VNDA | Vanda Pharmaceuticals Inc. | Mar 4, 2024 | 2 | -$73.3K | 4 | Mar 6, 2024 | SVP & General Counsel |
VNDA | Vanda Pharmaceuticals Inc. | Feb 16, 2024 | 1 | $0 | 4 | Feb 21, 2024 | SVP & General Counsel |
VNDA | Vanda Pharmaceuticals Inc. | Jun 13, 2023 | 1 | -$95.8K | 4 | Jun 15, 2023 | SVP & General Counsel |
VNDA | Vanda Pharmaceuticals Inc. | Mar 2, 2023 | 2 | -$105K | 4 | Mar 6, 2023 | SVP & General Counsel |
VNDA | Vanda Pharmaceuticals Inc. | Feb 16, 2023 | 2 | $0 | 4 | Feb 21, 2023 | SVP & General Counsel |
VNDA | Vanda Pharmaceuticals Inc. | Dec 15, 2022 | 1 | -$56.1K | 4 | Dec 16, 2022 | SVP & General Counsel |
VNDA | Vanda Pharmaceuticals Inc. | Aug 15, 2022 | 2 | -$85.5K | 4 | Aug 17, 2022 | SVP & General Counsel |
VNDA | Vanda Pharmaceuticals Inc. | Feb 28, 2022 | 3 | -$134K | 4 | Mar 2, 2022 | SVP & General Counsel |
VNDA | Vanda Pharmaceuticals Inc. | Aug 16, 2021 | 1 | -$60K | 4 | Aug 17, 2021 | SVP & General Counsel |